Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
189.39
+0.30 (0.16%)
Jun 6, 2025, 4:00 PM - Market closed
Universal Health Services Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$222.31
Upside
+17.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $211 → $201 | Hold | Maintains | $211 → $201 | +6.13% | Apr 30, 2025 |
| Barclays | Barclays | Buy Maintains $249 → $257 | Buy | Maintains | $249 → $257 | +35.70% | Apr 29, 2025 |
| Baird | Baird | Buy → Hold Downgrades $274 → $224 | Buy → Hold | Downgrades | $274 → $224 | +18.27% | Apr 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $208 | Strong Buy | Initiates | $208 | +9.83% | Apr 9, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $200 | Hold | Initiates | $200 | +5.60% | Mar 26, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $230 → $225 | Buy | Maintains | $230 → $225 | +18.80% | Mar 10, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $210 → $223 | Hold | Maintains | $210 → $223 | +17.75% | Feb 28, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $210 | Hold | Reiterates | $210 | +10.88% | Feb 27, 2025 |
| Barclays | Barclays | Buy Maintains $271 → $249 | Buy | Maintains | $271 → $249 | +31.47% | Feb 27, 2025 |
| JP Morgan | JP Morgan | Hold Initiates $226 | Hold | Initiates | $226 | +19.33% | Dec 17, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $275 → $251 | Strong Buy | Maintains | $275 → $251 | +32.53% | Nov 26, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $285 → $230 | Buy | Maintains | $285 → $230 | +21.44% | Nov 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $275 → $285 | Buy | Maintains | $275 → $285 | +50.48% | Nov 6, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $283 → $275 | Strong Buy | Maintains | $283 → $275 | +45.20% | Oct 28, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $222 → $211 | Hold | Maintains | $222 → $211 | +11.41% | Oct 28, 2024 |
| Barclays | Barclays | Buy Maintains $256 → $271 | Buy | Maintains | $256 → $271 | +43.09% | Oct 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.